chr15-59136459-C-G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_004998.4(MYO1E):​c.*921G>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.347 in 280,854 control chromosomes in the GnomAD database, including 17,653 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 10519 hom., cov: 31)
Exomes 𝑓: 0.32 ( 7134 hom. )

Consequence

MYO1E
NM_004998.4 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.558

Publications

17 publications found
Variant links:
Genes affected
MYO1E (HGNC:7599): (myosin IE) This gene encodes a member of the nonmuscle class I myosins which are a subgroup of the unconventional myosin protein family. The unconventional myosin proteins function as actin-based molecular motors. Class I myosins are characterized by a head (motor) domain, a regulatory domain and a either a short or long tail domain. Among the class I myosins, this protein is distinguished by a long tail domain that is involved in crosslinking actin filaments. This protein localizes to the cytoplasm and may be involved in intracellular movement and membrane trafficking. Mutations in this gene are the cause of focal segmental glomerulosclerosis-6. This gene has been referred to as myosin IC in the literature but is distinct from the myosin IC gene located on chromosome 17. [provided by RefSeq, Jan 2012]
MYO1E Gene-Disease associations (from GenCC):
  • focal segmental glomerulosclerosis 6
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • familial idiopathic steroid-resistant nephrotic syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.76).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.441 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYO1ENM_004998.4 linkc.*921G>C 3_prime_UTR_variant Exon 28 of 28 ENST00000288235.9 NP_004989.2 Q12965Q4KMR3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYO1EENST00000288235.9 linkc.*921G>C 3_prime_UTR_variant Exon 28 of 28 1 NM_004998.4 ENSP00000288235.4 Q12965
MYO1EENST00000559412.1 linkc.*226G>C 3_prime_UTR_variant Exon 3 of 3 3 ENSP00000453936.1 H0YNB0

Frequencies

GnomAD3 genomes
AF:
0.369
AC:
55975
AN:
151738
Hom.:
10501
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.446
Gnomad AMI
AF:
0.262
Gnomad AMR
AF:
0.429
Gnomad ASJ
AF:
0.356
Gnomad EAS
AF:
0.450
Gnomad SAS
AF:
0.264
Gnomad FIN
AF:
0.317
Gnomad MID
AF:
0.459
Gnomad NFE
AF:
0.320
Gnomad OTH
AF:
0.369
GnomAD4 exome
AF:
0.321
AC:
41396
AN:
128996
Hom.:
7134
Cov.:
0
AF XY:
0.315
AC XY:
22283
AN XY:
70778
show subpopulations
African (AFR)
AF:
0.432
AC:
1856
AN:
4298
American (AMR)
AF:
0.464
AC:
4292
AN:
9248
Ashkenazi Jewish (ASJ)
AF:
0.353
AC:
1053
AN:
2986
East Asian (EAS)
AF:
0.442
AC:
2975
AN:
6730
South Asian (SAS)
AF:
0.247
AC:
5993
AN:
24264
European-Finnish (FIN)
AF:
0.311
AC:
1546
AN:
4970
Middle Eastern (MID)
AF:
0.373
AC:
150
AN:
402
European-Non Finnish (NFE)
AF:
0.308
AC:
21561
AN:
69994
Other (OTH)
AF:
0.323
AC:
1970
AN:
6104
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1270
2540
3811
5081
6351
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
240
480
720
960
1200
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.369
AC:
56035
AN:
151858
Hom.:
10519
Cov.:
31
AF XY:
0.368
AC XY:
27338
AN XY:
74202
show subpopulations
African (AFR)
AF:
0.446
AC:
18455
AN:
41378
American (AMR)
AF:
0.429
AC:
6550
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.356
AC:
1237
AN:
3470
East Asian (EAS)
AF:
0.451
AC:
2323
AN:
5156
South Asian (SAS)
AF:
0.263
AC:
1263
AN:
4806
European-Finnish (FIN)
AF:
0.317
AC:
3346
AN:
10552
Middle Eastern (MID)
AF:
0.452
AC:
132
AN:
292
European-Non Finnish (NFE)
AF:
0.320
AC:
21713
AN:
67932
Other (OTH)
AF:
0.369
AC:
778
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1768
3536
5303
7071
8839
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
538
1076
1614
2152
2690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.344
Hom.:
1115
Bravo
AF:
0.384
Asia WGS
AF:
0.391
AC:
1356
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.76
CADD
Benign
13
DANN
Benign
0.66
PhyloP100
0.56
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4218; hg19: chr15-59428658; COSMIC: COSV55694936; COSMIC: COSV55694936; API